Target intelligence / Profile preview

(2R)-3-sulfolactate dehydrogenase (SLDH)

Target
SLDH
Molecular classification
Enzyme, Oxidoreductase, Dehydrogenase
01

Overview

(2R)-3-sulfolactate dehydrogenase (SLDH) is a bacterial and archaeal enzyme that plays a critical role in the catabolism of organosulfonates, such as sulfoquinovose and taurine-derived intermediates. It catalyzes the reversible NAD(P)+-dependent oxidation of 3-sulfolactate to 3-sulfopyruvate, a key step in pathways that allow microorganisms to extract energy and sulfur from sulfonated compounds abundant in plants and algae. In the human context, SLDH is found in specific members of the gut microbiota where its activity contributes to the production of downstream metabolites like hydrogen sulfide, which has complex implications for intestinal health and systemic metabolism. While it is not a direct target for current human pharmaceuticals, SLDH is an emerging focus in microbiome research due to its association with conditions such as obesity and inflammatory bowel disease. Structurally, SLDH is distinct from common dehydrogenases as it lacks the traditional Rossmann fold, making it a unique model for studying non-canonical oxidoreductase mechanisms.

Other names
3-sulfolactate dehydrogenase(R)-sulfolactate dehydrogenase(S)-sulfolactate dehydrogenaseL-sulfolactate dehydrogenaseComCSlcDDhpASlaB
02

Mechanism of action

None

03

Biological functions

Organosulfonate metabolismSulfur cyclingSulfoquinovose degradation (Sulfoglycolysis)Microbial energy productionTaurine metabolismOther
04

Disease associations

ObesityInflammationMetabolic syndromeOther
05

Safety considerations

Disruption of intestinal sulfur homeostasisPotential for excessive hydrogen sulfide production by gut microbiotaAlteration of gut microbiome metabolic profile
06

Biomarkers

3-sulfolactate (metabolite)Bacterial SLDH gene abundance in metagenomic samples

Beyond the preview

Go deeper on (2R)-3-sulfolactate dehydrogenase (SLDH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on (2R)-3-sulfolactate dehydrogenase (SLDH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call